Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Drewry

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Molecules (Basel, Switzerland)|October 13, 2021
Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid TumorsAndreas S Kalogirou, Michael P East, Tuomo Laitinen, et al.
Plos Neglected Tropical Diseases|January 12, 2016
Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoniThavy Long, R Jeffrey Neitz, Rachel Beasley, et al.
Plos One|August 4, 2017
Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypesMargarite D Matossian, Steven Elliott, Van T Hoang, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether seriesFrank Navas, Michael J Bishop, Deanna T Garrison, et al.
Journal of Medicinal Chemistry|October 24, 2023
Fused Tetrahydroquinolines Are Interfering with Your AssayFrances M Bashore, Joel Annor-Gyamfi, Yuhong Du, et al.
Plant Direct|November 30, 2022
An open source plant kinase chemogenomics setMaria Florencia Ercoli, Priscila Zonzini Ramos, Rashmi Jain, et al.
The Journal of Biological Chemistry|August 7, 2025
NUAK kinases: signaling mechanisms and therapeutic applicationsNicole M Cullen, Peter Rosston, Bakhtawar Tufail, et al.
Science Signaling|September 27, 2018
Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cellsDaniel M Foulkes, Dominic P Byrne, Wayland Yeung, et al.
Frontiers in Bioscience (Landmark Edition)|May 31, 2022
MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer TypesKhoa Nguyen, Minh N Tran, Andrew Rivera, et al.
European Journal of Medicinal Chemistry|April 18, 2024
Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationshipsChristopher R M Asquith, Michael P East, Tuomo Laitinen, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Molecules (Basel, Switzerland)|October 13, 2021
Synthesis and Evaluation of Novel 1,2,6-Thiadiazinone Kinase Inhibitors as Potent Inhibitors of Solid TumorsAndreas S Kalogirou, Michael P East, Tuomo Laitinen, et al.
Plos Neglected Tropical Diseases|January 12, 2016
Structure-Bioactivity Relationship for Benzimidazole Thiophene Inhibitors of Polo-Like Kinase 1 (PLK1), a Potential Drug Target in Schistosoma mansoniThavy Long, R Jeffrey Neitz, Rachel Beasley, et al.
Plos One|August 4, 2017
Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypesMargarite D Matossian, Steven Elliott, Van T Hoang, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2002
2-(anilinomethyl)imidazolines as alpha1A adrenergic receptor agonists: 2'-heteroaryl and 2'-oxime ether seriesFrank Navas, Michael J Bishop, Deanna T Garrison, et al.
Journal of Medicinal Chemistry|October 24, 2023
Fused Tetrahydroquinolines Are Interfering with Your AssayFrances M Bashore, Joel Annor-Gyamfi, Yuhong Du, et al.
Plant Direct|November 30, 2022
An open source plant kinase chemogenomics setMaria Florencia Ercoli, Priscila Zonzini Ramos, Rashmi Jain, et al.
The Journal of Biological Chemistry|August 7, 2025
NUAK kinases: signaling mechanisms and therapeutic applicationsNicole M Cullen, Peter Rosston, Bakhtawar Tufail, et al.
Science Signaling|September 27, 2018
Covalent inhibitors of EGFR family protein kinases induce degradation of human Tribbles 2 (TRIB2) pseudokinase in cancer cellsDaniel M Foulkes, Dominic P Byrne, Wayland Yeung, et al.
Frontiers in Bioscience (Landmark Edition)|May 31, 2022
MAP3K Family Review and Correlations with Patient Survival Outcomes in Various Cancer TypesKhoa Nguyen, Minh N Tran, Andrew Rivera, et al.
European Journal of Medicinal Chemistry|April 18, 2024
Discovery and optimization of narrow spectrum inhibitors of Tousled like kinase 2 (TLK2) using quantitative structure activity relationshipsChristopher R M Asquith, Michael P East, Tuomo Laitinen, et al.
Pageof 12